These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients. Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010253. PubMed ID: 24901467 [TBL] [Abstract][Full Text] [Related]
4. Antibody induction versus corticosteroid induction for liver transplant recipients. Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2014 May; 2014(5):CD010252. PubMed ID: 24880007 [TBL] [Abstract][Full Text] [Related]
5. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681 [TBL] [Abstract][Full Text] [Related]
16. Basiliximab: a review of its use as induction therapy in renal transplantation. Chapman TM; Keating GM Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658 [TBL] [Abstract][Full Text] [Related]
17. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Hong T; Zhang M; Fan J Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607 [TBL] [Abstract][Full Text] [Related]